In order to evaluate the prophylactic effect of oral magnesium, 81 patients aged 18–65 years with migraine according to the International Headache Society (IHS) criteria (mean attack frequency 3.6 per month) were examined. After a prospective baseline period of 4 weeks they received oral 600 mg (24 mmol) magnesium (trimagnesium dicitrate) daily for 12 weeks or placebo. In weeks 9–12 the attack frequency was reduced by 41.6% in the magnesium group and by 15.8% in the placebo group compared to the baseline (p < 0.05). The number of days with migraine and the drug consumption for symptomatic treatment per patient also decreased significantly in the magnesium group. Duration and intensity of the attacks and the drug consumption per attack also tended to decrease compared to placebo but failed to be significant. Adverse events were diarrhea (18.6%) and gastric irritation (4.7%). High-dose oral magnesium appears to be effective in migraine prophylaxis.
SwansonDRMigraine and magnesium: eleven neglected connections.Persp Biol Med1988;
31(4):
526–57
2.
FacchinettiFSancesGBorellaPGenazzaniARNappiGMagnesium prophylaxis of menstrual migraine: effects on intracellular magnesium,
Headache1991;
31:
298301
3.
SchoenenJSianard-GainkoJLenaertsMBlood magnesium levels in migraine.Cephalalgia1991;
11:
97–9
4.
SarchielliPCoataGFirenzeCMorucciPAbbrittiGGallaiVSerum and salivary magnesium levels in migraine and tension-type headache. Results in a group of adult patients.Cephalalgia1992;
12:
21–7
5.
GallaiVSarchielliPCoataGFirenzeCMorucci AbbrittiGSerum and salivary magnesium levels in migraine. Results in a group of juvenile patients.
Headache1992;
32:
1325
6.
GallaiVSarchielliPMorucciPAbbrittiG,
Red blood cell magnesium levels in migraine patients.
Cephalalgi1993;
13:
948
7.
GallaiVSarchielliPMorucciPAbbrittiGMagnesium content of mononuclear blood cells in migraine patientsHeadache1994;
34:
1605
8.
SorianiSArnaldiCDe CarloLArcudiDMazzottaDBattistellaPASartoriSAbbascianoVSerum and red blood cell magnesium levels in juvenile migraine patients.Headache1995;
35:
14–6
9.
SmeetsMCVernooyCBSouverijnJHMFerrariMDIntracellular and plasma magnesium in familial hemiplegic migraine and migraine with and without aura.Cephalalgia1994;
14:
29–32
10.
RamadanNMHalvorsonHVande-LindeALevineSRHelpernJAWelchKMALow brain magnesium in migraine.Headache1989;
29:
590–3
11.
JainACSethiNCBabbarPKA clinical electroencephalographic and trace element study with special reference to zinc, copper and magnesium in serum and cerebrospinal fluid (CSF) in cases of migraine.J Neurol1985;
232
Suppl:
161
12.
LauritzenMCortical spreading depression as a putative migraine mechanism.Trends Neurosci1987;
10:
8–13
13.
WelchKMAD'AndreaGTepleyNBarkleyGRamadanNMThe concept of migraine as a state of central neuronal hyperexcitability.Neurol Clin1990;
8(4):
817–28
14.
OlesenJUnderstanding the biologic basis of migraine.N Engl J Med1994;
331:
1713–4
15.
AlturaBMAlturaBTWithdrawal of magnesium causes vasospasm while elevated magnesium produces relaxation of tone in cerebral arteries.Neurosci Lett1980;
20:
323–7
16.
TurlapatyPDMVAlturaBMMagnesium deficiency produces spasms of coronary arteries: relationship to etiology of sudden death ischemic heart disease.Science1980;
208:
198–200
17.
AlturaBMAlturaBTCarellaAMagnesium deficiency-induced spasms of umbilical vessels: relation to preeclampsia, hypertension, growth retardation.Science1983;
221:
376–8
18.
NowakLBregestovskiPAscherPHerbetAProchiantzAMagnesium gates glutamate-activated channels in mouse central neurones.Nature1984;
307:
462–5
19.
AvoliMDrapeauCLouvelJPumainROlivierAVillemureJ-GEpileptiform activity induced by low extracellular magnesium in the human cortex maintained in vitro.Ann Neurol1991;
30:
58996
20.
ModyILambertJDCHeinemannULow extracellular magnesium induces epileptiform activity and spreading depression in rat hippocampal slices.J Neurophysiol1987;
57(3):
869–88
21.
Baudouin-LegrosMDardBGuichencyPHyperreactivity of platelets from spontaneously hypertensive rats. Role of external magnesium.Hypertension1986;
8:
694–9
22.
GallaiVSarchielliPFranceschiniMTrequattriniAFloridiAIs magnesium involved in the cytokine/neurogenic inflammation in migraine?Headache1994;
34:
297–8
23.
PinesNKieffMBLondLMSSAMagnesium sulphate in the treatment of angiospasm.
Lancet1933;
I:
5779
24.
Headache Classification Committee of the International Headache Society.Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain.Cephalalgia1988;
8Suppl 7:
1–96
25.
DienerHC,
A review of current treatments for migraine.
Eur Neurol1994;
34Suppl 2:
1825
26.
International Headache Society Committee on Clinical Trial:in Migraine. Guidelines for controlled trials of drugs in migraine. First edition.
Cephalalgia1991;
11:
112
27.
HolroydKAPenzienDBCordingleyGEPropranolol in the management of recurrent migraine: a meta-analytic reviewHeadache1991;
31:
33340
28.
WeaverMDMagnesium and migraine.Headache1990;
30:
168
29.
WilimzigCLatzRVierlingWMutschlerETrnovecTNyulassySIncrease in magnesium plasma level after orally administered trimagnesium dicitrate.Eur J Clin Pharmacol1996;
49:
317–23
30.
LucasMJLevenoKJCunninghamFGA comparison of magnesium sulfate with phenytoin for the prevention of eclampsia.N Engl J Med1995;
333:
201–5
31.
The Eclampsia Trial Collaborative Group.Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial.Lancet1995;
345:
1455–63
32.
WoodsKLFletcherSLong-term outcome after intravenous magnesium sulphate in suspected acute myocardial infarction: the second Leicester i ntravenous magnesium intervention trial (LIMIT-2).Lancet1994;
343:
816–9
33.
MuirKWKennedyRLClinical experience with excitatory amino acid antagonist drugs.Stroke1995;
26(3):
503–13
34.
MauskopAAlturaBTCraccoRQAlturaBMIntravenous magnesium sulfate relieves cluster headaches in patients with low serum ionized magnesium levels.Headache1995;
35:
287–8
